Abstract

Objective: This is the first report on the safety and clinical efficacy of a bone marrow mesenchymal cell extracellular vesicle isolate product (XoFlo™) to treat osteoarthritis (OA). Design, Setting, and Methods: Thirty-three Navy SEAL ..

Highlights

  • What causes the pain in osteoarthritis (OA)? The correlation between the imaging studies and reported pain is low

  • The synovium is of obvious relevance as the most densely innervated structure in the joint

  • Any decrease in synovitis is associated with a decrease in osteoarthritis pain severity [9]

Read more

Summary

Introduction

What causes the pain in osteoarthritis (OA)? The correlation between the imaging studies and reported pain is low. What causes the pain in osteoarthritis (OA)? Articular cartilage has no direct nerve or blood supply. Articular cartilage itself is not capable of directly generating pain [1]. The synovium and joint capsule are richly innervated and likely the primary source of pain in patients with OA [2]. The synovium is of obvious relevance as the most densely innervated structure in the joint. Pro-inflammatory cytokines including IL1-β, IL6, and IL8, along with tumor necrosis factor, are known mediators of chronic inflammation and associated pain in OA [8]. A semiquantitative measure of infrapatellar fat pad synovitis is associated with pain severity. Any decrease in synovitis is associated with a decrease in osteoarthritis pain severity [9]

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.